An ageing population around the world is one of the reasons the nanotechnology in medical devices market will hit $8.5 billion (£5.7 million) in 2019.
This is according to research from market analyst RnRMarketResearch, which claimed that nanotechnology in health is currently valued at around $5 billion, but is expected to grow annually about 12 percent up to 2019.
The firm said that nanotechnology is witnessing such fast growth because of an ageing population, along with increased governmental support and higher R&D spending.
Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.
In 2013, North America accounted for the largest share to the global nanotechnology in medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly ageing population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.
Tesla retreats from pioneering gigacasting manufacturing process, amid cost cutting and challenges at EV giant
No skynet please. After the US, UK and France pledge human only control of nuclear…
Microsoft's AI investments continue in south east Asia, after investments in Japan, Malaysia, Indonesia, as…
New chapter for LastPass as it becomes an independent company to focus on cybersecurity, after…
US FCC seeks to ban Chinese telecom firms at centre of national security concerns from…
Two updates to Anthropic's AI chatbot Claude sees arrival of a new business-focused plan, as…